|
|
 |
|
Viewing report
|
|
|
|
Indian Bulk Drug Market - Industry Insight
CYGNUS Business Consulting & Research, Oct 2010, Pages: 176
Indian bulk drug industry to grow to US$ 17 billion by 2014
The Indian Bulk Drug industry is expected to grow at a CAGR of 21% to reach US$16.91 billion by 2013-14 as per this study. Cygnus estimates the size of the Indian bulk drug industry for 2009-10 at US$ 11.54 billion, out of which exports contribute about US$ 7.5 billion, constituting 65% of the industry. The Indian Contract Manufacturing market stood at US$986m in 2009 and is expected to grow at a CAGR of 41.7% to reach US$5.63 billion by 2014.
India has the highest number of Drug Master Filings (DMF) amongst all key competing economies. From 2000-2008 India had more than 1614 filings, 3 times higher than that of China. Other Countries such as Italy, Spain, Mexico, Brazil etc are far behind as compared to India. The share of Drug Master Filings made by Indian firms has increased considerably from 14% in 2000 to 50% in 2009.
In view of the significant growth potential of the Indian bulk drugs industry, Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight. The report will be useful to senior executives associated with the industry, bankers, private equity players, investors, students, research scholars and industry analysts who need relevant industry inputs for their work.
SCOPE OF THE REPORT
- Global and Indian Bulk Drug Market
- Key Growth Drivers
- Industry Regulations
- Issues & Challenges
- Major Players – Business profile, Their Bulk Actives therapeutic segment wise, Strategies, M& A / Alliances, Financial Profile, SWOT Analysis and Future Outlook.
- Major Medical Institutes
- Critical Success Factors
- Future outlook
HIGHLIGHTS OF THE REPORT
- Major therapeutic categories and Annual Production of Major Bulk Drugs
- Major Deals Announced/Completed By Indian Companies
- Drug Patent Expirations
- ANDA Filings by Indian Companies
- R&D Expenditure
- DMF filings by Indian companies
- India's Advantages for Contract Manufacturing
- A Comparison between India and China
- 320 DMF filings by Indian companies
- List of Bulk Drugs Manufacturers in India
REASONS TO BUY
- Latest and Very Comprehensive report on Indian API Market
- Gives insights into Indian Pharma industry also along with the outsourcing market
- Lists of various sought after Data such as patent expirations, DMF, import - export etc
RELATED REPORTS
Indian Pharmaceutical Markets, Quarterly Update & Analysis on Indian Pharma, Indian Dental Market, Clinical Trials in India, CRAMS Market
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Indian Pharmaceutical Industry, Q4 2011
Industry Insight - Indian Bulk Drugs
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Comparisons of Pharmaceutical Manufacturing between China and India
Pharmaceuticals - Global Outlook
Global Active Pharmaceutical Ingredient Market (Api) Trends, Competitive Landscape And Forecasts (2011-2016)
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
Global Generics
Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
|
|
|
|
